Ultragenyx Pharm Inc Drug Patent Portfolio
Ultragenyx Pharm Inc owns 1 orange book drug protected by 2 US patents Given below is the list of Ultragenyx Pharm Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8697748 | Glycogen or polysaccharide storage disease treatment method | 28 Apr, 2029 | Active |
| US9186344 | Glycogen or polysaccharide storage disease treatment method | 01 Jul, 2025 | Active |
Latest Legal Activities on Ultragenyx Pharm Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ultragenyx Pharm Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Patent Term Extension Certificate
Critical
| 17 Oct, 2023 | US8697748 |
| Notice of Final Determination -Election Required | 06 Jun, 2023 | US9186344 |
| Notice of Final Determination -Election Required | 06 Jun, 2023 | US8697748 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 16 May, 2023 | US9186344 |
|
FDA Final Eligibility Letter
Critical
| 29 Aug, 2022 | US8697748 |
|
FDA Final Eligibility Letter
Critical
| 29 Aug, 2022 | US9186344 |
| transaction for FDA Determination of Regulatory Review Period | 05 Nov, 2021 | US9186344 |
| transaction for FDA Determination of Regulatory Review Period | 05 Nov, 2021 | US8697748 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Oct, 2021 | US8697748 |
| Second letter to regulating agency to determine regulatory review period | 20 May, 2021 | US8697748 |
| Second letter to regulating agency to determine regulatory review period | 20 May, 2021 | US9186344 |
| Letter from FDA or Dept of Agriculture re PTE application | 14 Dec, 2020 | US9186344 |
| Letter from FDA or Dept of Agriculture re PTE application | 14 Dec, 2020 | US8697748 |
| Initial letter Re: PTE Application to regulating agency | 13 Nov, 2020 | US8697748 |
| Initial letter Re: PTE Application to regulating agency | 13 Nov, 2020 | US9186344 |
Ultragenyx Pharm Inc's Family Patents
Ultragenyx Pharm Inc Drug List
Given below is the complete list of Ultragenyx Pharm Inc's drugs and the patents protecting them.
1. Dojolvi
Dojolvi is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8697748 | Glycogen or polysaccharide storage disease treatment method |
28 Apr, 2029
(4 years from now)
| Active |
| US9186344 | Glycogen or polysaccharide storage disease treatment method |
01 Jul, 2025
(7 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Dojolvi's drug page